Genetic variant in PSCA predicts survival of diffuse-type gastric cancer in a Chinese population

International Journal of Cancer

Volumn 129, Issue 5, 2011, Pages 1207-1213

  Wang, Meilin ^a,b   Bai, Jin ^a   Tan, Yongfei ^c   Wang, Shizhi ^a   Tian, Yuanyuan ^a   Gong, Weida ^c   Zhou, Yan ^c   Gao, Yan ^a   Zhou, Jianwei ^a,b   Zhang, Zhengdong ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Nanjing Medical University   (China)

^c YIXING PEOPLE S HOSPITAL   (China)

Author keywords

gastric cancer; GWAS; molecular epidemiology; PSCA; survival

Indexed keywords

PROSTATE STEM CELL ANTIGEN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CELL PROLIFERATION; CHINESE; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; STOMACH CANCER; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; GPI-LINKED PROTEINS; HAPLOTYPES; HUMANS; INTESTINAL NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; POLYMORPHISM, GENETIC; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 79959709447     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25740     Document Type: Article

References (26)

1. Parkin DM, Bray F, Ferlay J, Pisani P,. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108. (Pubitemid 40372904)
2. Hundahl SA, Phillips JL, Menck HR,. The National cancer data base report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: fifth edition American Joint Committee on Cancer staging, proximal disease, and the "different disease" hypothesis. Cancer 2000; 88: 921-32. (Pubitemid 30091113)
3. Parkin DM, Pisani P, Ferlay J,. Global cancer statistics. CA Cancer J Clin 1999; 49: 33-64, 1. (Pubitemid 29094960)
4. Catalano V, Labianca R, Beretta GD, Gatta G, de Braud F, Van Cutsem E,. Gastric cancer. Crit Rev Oncol Hematol 2009; 71: 127-64.
5. Ludwig JA, Weinstein JN,. Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer 2005; 5: 845-56. (Pubitemid 41746029)
6. Becker KF, Keller G, Hoefler H,. The use of molecular biology in diagnosis and prognosis of gastric cancer. Surg Oncol 2000; 9: 5-11.
7. Reiter RE, Gu Z, Watabe T, Thomas G, Szigeti K, Davis E, Wahl M, Nisitani S, Yamashiro J, Le Beau MM, Loda M, Witte ON,. Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer. Proc Natl Acad Sci USA 1998; 95: 1735-40. (Pubitemid 28103463)
8. Han KR, Seligson DB, Liu X, Horvath S, Shintaku PI, Thomas GV, Said JW, Reiter RE,. Prostate stem cell antigen expression is associated with gleason score, seminal vesicle invasion and capsular invasion in prostate cancer. J Urol 2004; 171: 1117-21. (Pubitemid 38327539)
9. Elsamman EM, Fukumori T, Tanimoto S, Nakanishi R, Takahashi M, Toida K, Kanayama HO,. The expression of prostate stem cell antigen in human clear cell renal cell carcinoma: a quantitative reverse transcriptase-polymerase chain reaction analysis. BJU Int 2006; 98: 668-73. (Pubitemid 44185896)
10. Elsamman E, Fukumori T, Kasai T, Nakatsuji H, Nishitani MA, Toida K, Ali N, Kanayama HO,. Prostate stem cell antigen predicts tumour recurrence in superficial transitional cell carcinoma of the urinary bladder. BJU Int 2006; 97: 1202-7. (Pubitemid 43907322)
11. Grubbs EG, Abdel-Wahab Z, Tyler DS, Pruitt SK,. Utilizing quantitative polymerase chain reaction to evaluate prostate stem cell antigen as a tumor marker in pancreatic cancer. Ann Surg Oncol 2006; 13: 1645-54. (Pubitemid 44951473)
12. Sakamoto H, Yoshimura K, Saeki N, Katai H, Shimoda T, Matsuno Y, Saito D, Sugimura H, Tanioka F, Kato S, Matsukura N, Matsuda N, et al. Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer. Nat Genet 2008; 40: 730-40. (Pubitemid 351748870)
13. Lu Y, Chen J, Ding Y, Jin G, Wu J, Huang H, Deng B, Hua Z, Zhou Y, Shu Y, Liu P, Hu Z, et al. Genetic variation of PSCA gene is associated with the risk of both diffuse- and intestinal-gastric cancer in a Chinese population. Int J Cancer 2010; 127: 2183-9.
14. Matsuo K, Tajima K, Suzuki T, Kawase T, Watanabe M, Shitara K, Misawa K, Ito S, Sawaki A, Muro K, Nakamura T, Yamao K, et al. Association of prostate stem cell antigen gene polymorphisms with the risk of stomach cancer in Japanese. Int J Cancer 2009; 125: 1961-4.
15. Ou J, Li K, Ren H, Bai H, Zeng D, Zhang C,. Association and haplotype analysis of prostate stem cell antigen with gastric cancer in Tibetans. DNA Cell Biol 2010; 29: 319-323.
16. Wu C, Wang G, Yang M, Huang L, Yu D, Tan W, Lin D,. Two genetic variants in prostate stem cell antigen and gastric cancer susceptibility in a Chinese population. Mol Carcinog 2009; 48: 1131-8.
17. Wu X, Ye Y, Kiemeney LA, Sulem P, Rafnar T, Matullo G, Seminara D, Yoshida T, Saeki N, Andrew AS, Dinney CP, Czerniak B, et al. Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer. Nat Genet 2009; 41: 991-5.
18. Wang S, Tang J, Wang M, Yuan L, Zhang Z,. Genetic variation in PSCA and bladder cancer susceptibility in a Chinese population. Carcinogenesis 2010; 31: 621-4.
19. Hohenberger P, Gretschel S,. Gastric cancer. Lancet 2003; 362: 305-15. (Pubitemid 36936845)
20. Saffran DC, Raitano AB, Hubert RS, Witte ON, Reiter RE, Jakobovits A,. Anti-PSCA mAbs inhibit tumor growth and metastasis formation and prolong the survival of mice bearing human prostate cancer xenografts. Proc Natl Acad Sci USA 2001; 98: 2658-63. (Pubitemid 32209538)
21. Gu Z, Yamashiro J, Kono E, Reiter RE,. Anti-prostate stem cell antigen monoclonal antibody 1G8 induces cell death in vitro and inhibits tumor growth in vivo via a Fc-independent mechanism. Cancer Res 2005; 65: 9495-500. (Pubitemid 41508019)
22. Crew KD, Neugut AI,. Epidemiology of gastric cancer. World J Gastroenterol 2006; 12: 354-62. (Pubitemid 43329250)
23. Moriguchi S, Maehara Y, Korenaga D, Sugimachi K, Hayashi Y, Nose Y,. Prediction of survival time after curative surgery for advanced gastric cancer. Eur J Surg Oncol 1992; 18: 287-92.
24. Adachi Y, Oshiro T, Mori M, Maehara Y, Sugimachi K,. Tumor size as a simple prognostic indicator for gastric carcinoma. Ann Surg Oncol 1997; 4: 137-40. (Pubitemid 127729056)
25. Moghimi-Dehkordi B, Safaee A, Zali MR,. Comparison of colorectal and gastric cancer: survival and prognostic factors. Saudi J Gastroenterol 2009; 15: 18-23.
26. Chanock SJ, Manolio T, Boehnke M, Boerwinkle E, Hunter DJ, Thomas G, Hirschhorn JN, Abecasis G, Altshuler D, Bailey-Wilson JE, Brooks LD, Cardon LR, et al. Replicating genotype-phenotype associations. Nature 2007; 447: 655-60. (Pubitemid 46889722)